Boston Scientific : Description Statement of Changes in Beneficial Ownership

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF

SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or

Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person *	2. Issuer Name and Ticker or Trading Symbol	5. Relationship of Reporting Person(s) to Issuer
		(Check all applicable)

Thepaut Eric Francis Yves

BOSTON SCIENTIFIC CORP [ BSX ]

_____ Director

_____ 10% Owner

(Last)

(First)

(Middle)

3. Date of Earliest Transaction (MM/DD/YYYY)

__X__ Officer (give title below) _____ Other (specify below)

300 BOSTON SCIENTIFIC WAY

2/21/2020

SVP & Pres, Eur, Mid-East, Afr

(Street)

4. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

MARLBOROUGH, MA 01752-1234

_X _ Form filed by One Reporting Person

(City)

(State)

(Zip)

___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security

2. Trans. Date

2A. Deemed

3. Trans. Code

4. Securities Acquired (A) or

5. Amount of Securities Beneficially Owned

6.

7. Nature

(Instr. 3)

Execution

(Instr. 8)

Disposed of (D)

Following Reported Transaction(s)

Ownership

of Indirect

Date, if any

(Instr. 3, 4 and 5)

(Instr. 3 and 4)

Form:

Beneficial

Direct (D)

Ownership

or Indirect

(Instr. 4)

(A) or

(I) (Instr.

Code

V

Amount

(D)

Price

4)

Common Stock

2/21/2020

M

1713.0000

A

$0.0000 (1)

90633.9900

D

Common Stock

2/21/2020

F

955.0000

D

$42.6200

89678.9900

D

Common Stock

2/22/2020

M

2028.0000

A

$0.0000 (1)

91706.9900

D

Common Stock

2/22/2020

F

1130.0000

D

$42.6200

90576.9900

D

Common Stock

2/23/2020

M

920.0000

A

$0.0000 (1)

91496.9900

D

Common Stock

2/23/2020

F

513.0000

D

$42.6200

90983.9900

D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of

2.

3. Trans.

3A. Deemed

4. Trans.

5. Number of

6. Date Exercisable and

7. Title and Amount of

8. Price of

9. Number of

10.

11. Nature

Derivate Security

Conversion

Date

Execution

Code

Derivative Securities

Expiration Date

Securities Underlying

Derivative

derivative

Ownership

of Indirect

(Instr. 3)

or Exercise

Date, if any

(Instr. 8)

Acquired (A) or

Derivative Security

Security

Securities

Form of

Beneficial

Price of

Disposed of (D)

(Instr. 3 and 4)

(Instr. 5)

Beneficially

Derivative

Ownership

Derivative

(Instr. 3, 4 and 5)

Owned

Security:

(Instr. 4)

Security

Amount or

Following

Direct (D)

Date

Expiration

Reported

or Indirect

Code

V

(A)

(D)

Exercisable

Date

Title

Number of

Transaction(s)

(I) (Instr.

Shares

(Instr. 4)

4)

Deferred Stock

(1)

2/21/2020

M

1713.0000

(2)

2/21/2023 (2)

Common

1713.0000

$0.0000

5141.0000

D

Units

Stock

Deferred Stock

(1)

2/22/2020

M

2028.0000

(3)

2/22/2021 (3)

Common

2028.0000

$0.0000

2028.0000

D

Units

Stock

Deferred Stock

(1)

2/23/2020

M

920.0000

(4)

2/23/2020 (4)

Common

920.0000

$0.0000

0.0000

D

Units

Stock

Explanation of Responses:

1. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
3. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
4. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

Reporting Owners

Reporting Owner Name / Address	Relationships
Director 10% Owner Officer	Other

Thepaut Eric Francis Yves

300 BOSTON SCIENTIFIC WAYSVP & Pres, Eur, Mid-East, Afr MARLBOROUGH, MA 01752-1234

Signatures

/s/ Scott G. Hodgdon, Attorney-in-Fact	2/24/2020
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).
• Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
  Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.